Westlake Genetech
西湖云谷智药
Westlake Genetech (西湖云谷智药) is a Hangzhou-based biotech startup applying artificial intelligence to gene-editing therapeutics, founded in February 2021 by Ma Lijia, a principal investigator at Westlake University's School of Life Sciences . The company built an AI-driven platform called AIdit to accelerate CRISPR therapy development, and has used deep-learning models trained on hundreds of thousands of gRNA sequences to predict CRISPR performance across multiple dimensions . Its research focus has expanded from core gene-editing tools to AAV delivery vector engineering and in vivo CAR-T approaches, with Ma presenting AAV and in vivo CAR-T results at the 2025 ESGCT annual meeting . Gaorong Ventures led the company's angel round in 2021 and subsequently participated in its Pre-A round .
AI-generated — may contain errors, please verify.
Coverage
Westlake Valley Intelligent Pharma: Cracking the AAV Delivery Challenge with AI, Entering the Super Track of In Vivo CAR-T — Gene Therapy's Moment in China | Gaorong Future
Chinese gene therapies have a real shot at genuine innovation — even leapfrogging the competition.
高榕创投·At the Intersection of Generative AI and Life Sciences: Technology Acceleration on One Side, Clinical Demand on the Other | Ronghui x NVIDIA Inception Program
NVIDIA, Gaorong Ventures, and Cornerstone Robotics on the Acceleration of "AI + Healthcare"
高榕创投·Ma Lijia of Westlake Yungu Intelligence Pharma: AI Knocks on the Door to a Cure for Gene-Editing Therapies | Gaorong Ventures
AI for Science in practice.
高榕创投·New drug development, energy storage, computing, and semiconductors see breakthrough innovations: homegrown R&D, world-first technologies, and AI-driven advances
Constantly creating new possibilities.
高榕创投·Medtech Entrepreneurship Is a "Game for the Brave": How to Sharpen Innovation, Product, and Organizational Capabilities | Ronghui
Discussing trends in medical technology innovation and upgrading R&D team organizational management.
高榕创投·Rongbao · May | Pinduoduo Enters the Era of 800 Million Users, Waterdrop Inc. Debuts on the NYSE
Meeting the needs of China's vast user base for a better life.
高榕创投·Westlake Valley Intelligent Pharma Raises Tens of Millions of RMB in Angel Round, AI Powers Gene-Editing Therapeutics
Dedicated to establishing a complete, end-to-end pipeline for applying AI technology in gene therapy.
高榕创投·
